Since the stock is trading temporarily way below fair value due to debt issues that have been resolved, the oil price is a non issue.
And he has been dead wrong for 5 years,
SXE going way higher.
Couldn't disagree with you more.
Ridiculously cheap stocks skyrocket just when you think they never will.
Any tips appreciated.
You have no idea what you are talking about.
There are no liquidity or debt service issues.
If there were they would have to disclose it.
Balance sheet is same as it has been for years.
What on earth are you talking about?
The MCZ balance sheet is basically the same as its been for years
Their are no issues they make their interest payments.
No creditor in their mind would pull the plug on a cash flow positive compan6m
With debt issue resolved there is no longer any logical reason to trade below $8 based on EBITDA multiples.
The thought that there are actually women like this is horrifying.
cap tech you are a sharp cookie and I admire your optimism but I think your looking at this with rose color glasses. Sold half at .27 and hoping for it to go back there so I can sell the other half.
Thanks your da man.
Any other dirt cheap stocks you like?
My favorite is LIVE:NASDAQ ($1,58) trades at 4 x EBITDA.
Recent Insider buying and just announced record sales month.
Huge growth market, synthetic turf.
The Hedge funds have been accumulating for months.
Now its time for them to pump it.
Another milestone for 2016 includes the continued discussions with RPX, as are required under the partial license sold to RPX in November of 2015. Spherix is committed to continuing those discussions in good faith and we hope to reach a fair and reasonable license. By agreement, these discussions can continue until May 23rd of this year. If an agreement is not reached by May 23rd, then the agreed "stay" on litigation expires and the number of potential licensees to our portfolio increases significantly
You still don't get my point.
When SXE was in debt compliance a year ago it had a market cap of $300 million.
SXE will now be in compliance again and now has a market cap of $30 million with the new shares.
Sir, when I refer to small I mean in relation to worst case issuance of 50 million.
The way I saw it the biggest risk under restructuring was massive dilution under CURE. With only about 10 million more shares issued and the debt compliance issues solved, shouldn't SXE be in the double digits based on where share price was before the debt issues started?
MSTX should be $1 right now with huge market for drug and likelihood of success.
They can't hold this back any longer.